BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30242697)

  • 1. Molecular, functional, and gene expression analysis of zebrafish Ror1 receptor.
    Bai Y; Liu C; Zhou J; Rong X; Wang H
    Fish Physiol Biochem; 2019 Feb; 45(1):355-363. PubMed ID: 30242697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomics on ROR1 and ROR2 orthologs.
    Katoh M; Katoh M
    Oncol Rep; 2005 Nov; 14(5):1381-4. PubMed ID: 16211313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
    Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
    J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation.
    Qi X; Okinaka Y; Nishita M; Minami Y
    Genes Cells; 2016 Apr; 21(4):325-34. PubMed ID: 26840931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal expression of bone morphogenetic protein family ligands and receptors in the zebrafish ovary: a potential paracrine-signaling mechanism for oocyte-follicle cell communication.
    Li CW; Ge W
    Biol Reprod; 2011 Nov; 85(5):977-86. PubMed ID: 21734261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
    Hasan MK; Yu J; Chen L; Cui B; Widhopf Ii GF; Rassenti L; Shen Z; Briggs SP; Kipps TJ
    Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.
    Kamizaki K; Doi R; Hayashi M; Saji T; Kanagawa M; Toda T; Fukada SI; Ho HH; Greenberg ME; Endo M; Minami Y
    J Biol Chem; 2017 Sep; 292(38):15939-15951. PubMed ID: 28790171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
    Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
    Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.
    Hasan MK; Yu J; Widhopf GF; Rassenti LZ; Chen L; Shen Z; Briggs SP; Neuberg DS; Kipps TJ
    Blood; 2018 Jul; 132(2):170-178. PubMed ID: 29678828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.
    Bainbridge TW; DeAlmeida VI; Izrael-Tomasevic A; Chalouni C; Pan B; Goldsmith J; Schoen AP; Quiñones GA; Kelly R; Lill JR; Sandoval W; Costa M; Polakis P; Arnott D; Rubinfeld B; Ernst JA
    PLoS One; 2014; 9(7):e102695. PubMed ID: 25029443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-canonical Wnt receptor Ror2 is required for cartilage cell polarity and morphogenesis of the craniofacial skeleton in zebrafish.
    Dranow DB; Le Pabic P; Schilling TF
    Development; 2023 Apr; 150(8):. PubMed ID: 37039156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.
    Yu J; Chen L; Chen Y; Hasan MK; Ghia EM; Zhang L; Wu R; Rassenti LZ; Widhopf GF; Shen Z; Briggs SP; Kipps TJ
    Leukemia; 2017 Dec; 31(12):2608-2614. PubMed ID: 28465528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
    Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
    Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular, functional, and gene expression analysis of zebrafish hypoxia-inducible factor-3α.
    Zhang P; Lu L; Yao Q; Li Y; Zhou J; Liu Y; Duan C
    Am J Physiol Regul Integr Comp Physiol; 2012 Dec; 303(11):R1165-74. PubMed ID: 23034716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.
    Hasan MK; Rassenti L; Widhopf GF; Yu J; Kipps TJ
    Leukemia; 2019 Mar; 33(3):653-661. PubMed ID: 30568170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.